← Open Payments lookup

JOHN STOLTZFUS: Open Payments

NPI 1740247956 · HERMITAGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$395 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $395

Food & beverage: $395
CompanyPaymentsAmount
Lilly USA, LLC3$54
Novo Nordisk Inc3$53
Amgen Inc.2$37
Eisai Inc.2$36
AstraZeneca Pharmaceuticals LP2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Takeda Pharmaceuticals U.S.A., Inc.2$33
Astellas Pharma US Inc1$20
ABBVIE INC.1$18
Sumitomo Pharma America, Inc.1$16

Products named: MOUNJARO, OTEZLA, Leqembi, CAPLYTA, TRINTELLIX, AIRSUPRA, Veozah, Ozempic.

Industry payments across PA — which companies pay providers there.